Drug Shortage Report for LEVOTHYROXINE SODIUM FOR INJECTION

Last updated on 2023-03-06 History
Report ID 183509
Drug Identification Number 02461722
Brand name LEVOTHYROXINE SODIUM FOR INJECTION
Common or Proper name Levothyroxine 500mcg
Company Name AVIR PHARMA INC.
Market Status MARKETED
Active Ingredient(s) LEVOTHYROXINE SODIUM
Strength(s) 500MCG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size vial
ATC code H03AA
ATC description THYROID PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-03-01
Actual start date
Estimated end date 2023-03-03
Actual end date 2023-03-02
Shortage status Resolved
Updated date 2023-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOULEVARD INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-03-06 French Compare
v11 2023-03-06 English Compare
v10 2023-03-02 English Compare
v9 2023-02-27 French Compare
v8 2023-02-27 English Compare
v7 2023-02-24 English Compare
v6 2023-02-17 French Compare
v5 2023-02-17 English Compare
v4 2023-02-14 English Compare
v3 2023-02-03 French Compare
v2 2023-02-03 French Compare
v1 2023-02-03 English Compare

Showing 1 to 12 of 12